159 related articles for article (PubMed ID: 9094675)
21. Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease.
Tracy S; Chapman NM; Romero J; Ramsingh AI
Trends Microbiol; 1996 May; 4(5):175-9. PubMed ID: 8727596
[TBL] [Abstract][Full Text] [Related]
22. Genetics of coxsackievirus virulence.
Chapman NM; Ramsingh AI; Tracy S
Curr Top Microbiol Immunol; 1997; 223():227-58. PubMed ID: 9294932
[No Abstract] [Full Text] [Related]
23. Structural and functional analysis of the 5' untranslated region of coxsackievirus B3 RNA: In vivo translational and infectivity studies of full-length mutants.
Liu Z; Carthy CM; Cheung P; Bohunek L; Wilson JE; McManus BM; Yang D
Virology; 1999 Dec; 265(2):206-17. PubMed ID: 10600593
[TBL] [Abstract][Full Text] [Related]
24. Molecular analysis of the echovirus 18 prototype: evidence of interserotypic recombination with echovirus 9.
Andersson P; Edman K; Lindberg AM
Virus Res; 2002 Apr; 85(1):71-83. PubMed ID: 11955640
[TBL] [Abstract][Full Text] [Related]
25. Attenuation of a reactivated cardiovirulent coxsackievirus B3: The 5'-nontranslated region does not contain major attenuation determinants.
Zhang HY; Yousef GE; Cunningham L; Blake NW; OuYang X; Bayston TA; Kandolf R; Archard LC
J Med Virol; 1993 Oct; 41(2):129-37. PubMed ID: 8283174
[TBL] [Abstract][Full Text] [Related]
26. Coxsackievirus B1-induced murine myositis: no evidence for viral persistence.
Zoll J; Jongen P; Galama J; van Kuppeveld F; Melchers W
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2071-6. PubMed ID: 8409931
[TBL] [Abstract][Full Text] [Related]
27. Coxsackievirus B3 infection and its mutation in Keshan disease.
Ren LQ; Li XJ; Li GS; Zhao ZT; Sun B; Sun F
World J Gastroenterol; 2004 Nov; 10(22):3299-302. PubMed ID: 15484304
[TBL] [Abstract][Full Text] [Related]
28. Virulence of swine vesicular disease virus is determined at two amino acids in capsid protein VP1 and 2A protease.
Kanno T; Mackay D; Wilsden G; Kitching P
Virus Res; 2001 Nov; 80(1-2):101-7. PubMed ID: 11597755
[TBL] [Abstract][Full Text] [Related]
29. Selenium and viral virulence.
Levander OA; Beck MA
Br Med Bull; 1999; 55(3):528-33. PubMed ID: 10746343
[TBL] [Abstract][Full Text] [Related]
30. Generation of an infectious cDNA of a highly cardiovirulent coxsackievirus B3(CVB3m) and comparison to other infectious CVB3 cDNAs.
Lee C; Maull E; Chapman N; Tracy S; Wood J; Gauntt C
Virus Res; 1997 Aug; 50(2):225-35. PubMed ID: 9282787
[TBL] [Abstract][Full Text] [Related]
31. Role of GNRA motif mutations within stem-loop V of internal ribosome entry segment in coxsackievirus B3 molecular attenuation.
M'hadheb-Gharbi MB; El Hiar R; Paulous S; Jaïdane H; Aouni M; Kean KM; Gharbi J
J Mol Microbiol Biotechnol; 2008; 14(4):147-56. PubMed ID: 17693702
[TBL] [Abstract][Full Text] [Related]
32. Attenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3.
Stadnick E; Dan M; Sadeghi A; Chantler JK
J Virol; 2004 Dec; 78(24):13987-4002. PubMed ID: 15564506
[TBL] [Abstract][Full Text] [Related]
33. Coxsackievirus B1-induced chronic inflammatory myopathy: differences in induction of autoantibodies to muscle and nuclear antigens by cloned myopathic and amyopathic viruses.
Tam PE; Fontana DR; Messner RP
J Lab Clin Med; 2003 Sep; 142(3):196-204. PubMed ID: 14532908
[TBL] [Abstract][Full Text] [Related]
34. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses.
Chapman NM; Tu Z; Tracy S; Gauntt CJ
Arch Virol; 1994; 135(1-2):115-30. PubMed ID: 8198437
[TBL] [Abstract][Full Text] [Related]
35. Coxsackieviral proteins functionally recognize the polioviral cloverleaf structure of the 5'-NTR of a chimeric enterovirus RNA: influence of species-specific host cell factors on virus growth.
Zell R; Klingel K; Sauter M; Fortmüller U; Kandolf R
Virus Res; 1995 Dec; 39(2-3):87-103. PubMed ID: 8837877
[TBL] [Abstract][Full Text] [Related]
36. Molecular epidemiology of coxsackievirus type B1.
Abdelkhalek I; Seghier M; Yahia AB; Touzi H; Meddeb Z; Triki H; Rezig D
Arch Virol; 2015 Nov; 160(11):2815-21. PubMed ID: 26243282
[TBL] [Abstract][Full Text] [Related]
37. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.
Kim KS; Tracy S; Tapprich W; Bailey J; Lee CK; Kim K; Barry WH; Chapman NM
J Virol; 2005 Jun; 79(11):7024-41. PubMed ID: 15890942
[TBL] [Abstract][Full Text] [Related]
38. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates.
Beck MA; Shi Q; Morris VC; Levander OA
Nat Med; 1995 May; 1(5):433-6. PubMed ID: 7585090
[TBL] [Abstract][Full Text] [Related]
39. Coxsackievirus B3 clinical isolates and murine myocarditis.
Gauntt CJ; Pallansch MA
Virus Res; 1996 Mar; 41(1):89-99. PubMed ID: 8725105
[TBL] [Abstract][Full Text] [Related]
40. Mutations in the 5' NTR and the Non-Structural Protein 3A of the Coxsackievirus B3 Selectively Attenuate Myocarditogenicity.
Massilamany C; Gangaplara A; Basavalingappa RH; Rajasekaran RA; Vu H; Riethoven JJ; Steffen D; Pattnaik AK; Reddy J
PLoS One; 2015; 10(6):e0131052. PubMed ID: 26098885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
